Endoscopic methods and systems for gastrointestinal reshaping and resurfacing
AssigneeEndolastic, Inc.
InventorsFrederick Haller, Paul Robertson
Life of this patent
Estimating the term…
Abstract
Non-resective endoscopic systems and methods for reshaping gastrointestinal organs to treat gastroesophageal reflux disease (GERD), obesity, Type 2 Diabetes Mellitus, and perforations. The non-resective endoscopic systems and methods provide improved tissue capture capacity to create pressure necrosis to target tissue areas. The non-resective endoscopic systems and methods include banding target tissue areas utilizing a ligation band. The ligation band creates a uniform distribution of pressure to improve tissue retention and pressure necrosis for eliciting a healing response.
Claims20
An endoscopic system for gastrointestinal reshaping, the endoscopic system comprising:
- an endoscope including at least one end barrel;
- and
- at least one ligation band;
- wherein the endoscope is operable to capture a tissue area corresponding to a patient, wherein the captured tissue area includes at least one of a mucosal layer, a submucosal layer, or a portion of a muscular layer;
- and
- wherein the at least one ligation band is operable to band the captured tissue area;
- and
- wherein, once the captured tissue area is banded, the at least one ligation band generates pressure across the banded tissue, wherein the banded tissue undergoes pressure necrosis to elicit a healing response.
A method for reshaping gastrointestinal tissue comprising:
- identifying a body passageway for narrowing, wherein narrowing the body passageway will improve a patient's condition;
- capturing, via an endoscopic device, at least one tissue area corresponding to the identified body passageway;
- deploying at least one ligation band to the at least one tissue area;
- and
- banding, via the at least one ligation band, the at least one tissue area, wherein the at least one tissue area undergoes pressure necrosis to elicit a healing response.
A method of treating gastrointestinal tissue comprising:
- identifying a body passageway to treat at least one patient condition, wherein the at least one patient condition includes at least one of gastroesophageal reflux disease (GERD), obesity, Type 2 Diabetes Mellitus, or perforation closure;
- capturing, via an endoscopic device, at least one tissue area corresponding to the identified body passageway;
- deploying at least one elastomeric ligation band to the at least one tissue area;
- and
- banding, via the at least one elastomeric ligation band, the at least one tissue area, wherein, as a result of the banding, the at least one tissue area undergoes pressure necrosis to elicit a natural healing response.
Dependencies are inferred from the claim text.